Novocardia Raises $53.7M in Series A Funding


Novocardia, a NYC-based provider of a cardiovascular care delivery platform, raised $53.7m in Series A financing.

The round was led by Deerfield Management Company.

The company intends to use the funds to build out its care delivery network of cardiology practices, develop its proprietary actuarial and quality-focused analytics platform and deploy its cardiovascular disease care model. 

Founded in 2020 by two cardiologists, Dr. Dan Blumenthal, and Dr. Julius Torelli, FACC, Novocardia supports cardiologists in building sustainable practices which are focused on proactive approaches to treating and preventing cardiovascular disease. The company provides partner practices with access to purpose-built analytics and point-of-care tools designed to improve cardiovascular health. Additionally, Novocardia will facilitate building symbiotic relationships with health plans and primary care partners, along with an array of other capabilities, including implementation of quality and process improvement efforts, value-focused clinical programs, growth and development services, support for traditional back-office functions, and technology-enabled care delivery.